Furthermore, a randomized clinical trial showed that MRE11 deficiency is associated with improved long-term disease-free survival and overall survival (OS) in a subset of stage III colon cancer patients [13], and Yuan SS et al. showed that high MRE11 expression is associated with increased malignant behaviour in breast cancer [14]. The gene discussed is MRE11; the disease is breast carcinoma.